Video

Dr. Alexandra Rogers recaps OAB research from SUFU 2022

Abstracts highlight topics such as sacral neuromodulation and percutaneous tibial nerve stimulation.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      In this video, Alexandra Rogers, MD, gives an overview of notable overactive bladder research presented at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction 2022 Winter Meeting in San Diego, California. Rogers is a urologist in Boulder, Colorado.

      The following abstracts are summarized:

      Poster M17: Patient preference of third line therapy for overactive bladder

      Poster M18: Determining patient preferences in the treatment of medication-refractory overactive bladder

      Poster M12: Trends in overactive bladder therapy utilization: an evaluation of the impact of clinical care pathways and practice guidelines

      Poster M11: Use of neuromodulation and chemodenervation for overactive bladder among FPMRS-certified urologists

      Clinical Science Abstract 11: Change in practice patterns following female urology subspecialization: an analysis of case logs among certifying urologists

      Poster M10: Fixed – life vs. rechargeable sacral neuromodulation (SNM): patient choice and device specific satisfaction

      Poster NM108: Slower than anticipated adoption of the InterStim Micro

      Clinical Science Abstract 21: InterStim Micro improves quality of life in overactive bladder subjects at 3- month follow up in a global, prospective, post-market study

      Poster NM109: History of sacral neuromodulation in urology

      Poster NM115: Simple anchor technique prevents migration of sacral neuromodulation test leads

      Clinical Science Abstract 18: Treatment of urinary urgency incontinence (UUI) with an ultra-miniaturized sacral nerve modulation (SNM) system: outcomes of the SANS-UUI feasibility study

      Poster OM40: Does success with posterior tibial nerve stimulation predict conversion to sacral neuromodulation?

      Poster OM38: Oasis pivotal trial to evaluate the safety and efficacy of the Renova iStim system for the treatment of women with OAB

      Poster OM37: OAB patient reported outcome improvements after 12 weeks of using a wearable surgery free, closed-loop bladder modulation system in a home setting - a feasibility trial

      Poster NM114: A closed-loop, surgery-free wearable bladder modulation system with objective confirmation of nerve activation is easy to use and can improve OAB symptoms in 12 weeks

      Clinical Science Abstract 8: Noninvasive spinal neuromodulation improves symptoms in patients with neurogenic bladder after stroke

      Clinical Science Abstract 24: Noninvasive spinal neuromodulation mitigates symptoms of overactive bladder

      © 2025 MJH Life Sciences

      All rights reserved.